semaglutide uses Live Updates on Semaglutide's Current and Future Active ingredient in Ozempic, Wegovy

The Optimal Medical Group add DEXA scans, body composition testing, or even genetic panels to evaluate how a patient's body's ability to process food and store fat may affect treatment

W.LeeM.-S.et al (2014)

Currently, the FDA has approved three GLP-1 RAs for obesity treatment: liraglutide, semaglutide and tirzepatide

Lactobacillus , Prevotella , Bacteroides , Desulfovibrio , and Oxalobacter spp

People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications

Both represent a step beyond current FDA-approved options